Physician profile
Bridget B Walker
NPI 1750768156
$41,321.73
in general payments reported to CMS, 2019-2025
12 companies · $464 in 2025
The $464 reported for 2025 was more than what 77% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $232 · 2021: $155 · 2022: $85.49 · 2023: $418 · 2024: $487 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,369.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saol Therapeutics INC. | $32,500.00 | 2019 | |
| Medtronic USA, INC. | $6,810.21 | 2019 | |
| Merz Pharmaceuticals, LLC | $755.76 | 2021-2025 | Xeomin |
| Ipsen Biopharmaceuticals, INC | $719.11 | 2020-2025 | Dysport |
| Abbvie INC. | $184.49 | 2023-2025 | Botox |
| Alexion Pharmaceuticals, INC. | $123.68 | 2019 | |
| Mdd US Operations, LLC | $119.20 | 2020 | |
| Merz North America, INC. | $26.16 | 2019 | |
| Medtronic, INC. | $25.46 | 2025 | Synchromedii |
| Averitas Pharma INC. | $23.47 | 2025 | Qutenza |
| Allergan, INC. | $20.48 | 2019 | |
| Pfizer INC. | $13.71 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.